PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14970889-7	2004	However, mPAP was significantly increased in hyopxic + L-NAME group as compared with hypoxic groups, and at the same time, the plasma concentration of NO was markedly decreased.	NG-Nitroarginine Methyl Ester	55-61	phospholipid phosphatase 1	Mus musculus	9-13	
31063821-7	2019	Further, acute hypoxic challenge in lowland lambs infused with l-NAME markedly increased their mPAP and PVR to values greater than baseline, whilst in highland animals under NO synthesis blockade, these variables did not show additional increase in response to low PO2.	NG-Nitroarginine Methyl Ester	63-69	phospholipid phosphatase 1	Mus musculus	95-99	
16338149-10	2006	Additionally, the pulmonary vascular stimulants acute hypoxia and L-NAME provoked a 63% and 86% increase MPAP, respectively.	NG-Nitroarginine Methyl Ester	66-72	phospholipid phosphatase 1	Mus musculus	105-109	
12047097-14	2002	These results demonstrate that L-NAME increased the myocardial contractility and PAP, whereas SNP transiently reversed the effects of L-NAME on myocardial contractility and PAP.	NG-Nitroarginine Methyl Ester	31-37	phospholipid phosphatase 1	Mus musculus	81-84	
10074245-7	1997	Long-term administration of L-NAME in hypoxic rats markedly inhibited the enhancement of cNOS enzyme activity, the production of EDNO and cGMP content in rat lungs, consequently it significantly decreased mPAP but elevated CAPs obviously.	NG-Nitroarginine Methyl Ester	28-34	phospholipid phosphatase 1	Mus musculus	205-209	
7780824-3	1995	NG-nitro-L-arginine methylester (L-NAME), an inhibitor of nitric oxide synthase, increased the peak value of mPAP and PVR during hypoxic ventilation to 4.9 +/- 0.6 kPa and 160.9 +/- 34.6kPa.	NG-Nitroarginine Methyl Ester	33-39	phospholipid phosphatase 1	Mus musculus	109-113